Get in Touch

Jul 01, 2015
You are here article details

US FDA’s Alert On Wockhardt: Much Ado About Nothing?

| 5/30/2013 9:02 PM Thursday

Pharma giant Wockhardt has received a strong setback after the US FDA sounded an alert on its Waluj manufacturing facility, after which the stock was hammered by more than 25 per cent in just two trading sessions. The market, however, seems to be overreacting to these developments. Shrikant Akolkar tells us more.

One of the worst things to happen to any stock is for it to get hit by factors which are apparently serious but on deeper exploration seem to be routine. This happens chiefly due to investors’ knee-jerk reaction to news flows which creates humongous negativity around it. One company which has recently been hit by this syndrome is Wockhardt.

We had recommended Wockhardt in DSIJ Vol. 28, Issue # 9 (dated 21 April, 2013) in our cover story ‘Cherry Picking’. The scrip was severely hammered following the recent US FDA alert on its manufacturing facility located in Waluj, Aurangabad district of Maharashtra. In just two trading sessions alone (May 23 and 24, 2013) it lost more than 25 per cent in value. Currently, the stock is down 35 per cent from where we had recommended it. Investors who have acted on our advice would surely be jittery in the wake of such a slide in the stock’s price. What should their future course in this counter be? Should one sell and book losses or wait out the depression? Here are the answers that you would be looking out for.

To start with, the hammering of the stock was a knee-jerk reaction arising out of fears fuelled by a particular event. This fear was accentuated by many other factors that were external to the company. The principal factor among these was the developments in Ranbaxy earlier in the same week.

Ranbaxy, the pharma company now owned by Daichhi Sankyo, pleaded guilty before the United States Department of Justice on compliance related issues in two of its manufacturing facilities. This was in any case weighing heavily on pharma stocks. The alert on Wockhardt’s Waluj facility came immediately after this, and dampened the sentiment on the stock.

What is worth noting is that Ranbaxy had ignored earlier malpractices, the consequences of which it had to bear. Wockhardt, however, had invited the US FDA team to audit its new injectables unit at Waluj. This is what differentiates between the two companies.

Find More Articles on: DSIJ Magazine, Special Report, Stock Recommendations, Fundamental Picks, Product, Large Cap

«« First « Previous |1 2 | Last ››

Related Readings

Top 10 companies with Lowest Foreign Institutional Investors (FIIs) Holding in BSE 100 Companies Exclusive

LatestMost PopularMarket Action

Indices End On Day’s High

The Indian markets saw a flattish scenario, however it closed trades on a higher note today. On the closing buzz, the indices like Healthcare and Consumer Durables saw an excellent up-move and pulled the indices on higher side. The Nifty ended up by 50 points at 8368 and Sensex was up by 135 points at 27780. Both indices ended higher in the range of .40-.60 percent.

Power Transmission Projects Persprective in FY16

Government is going to invite bids of Rs 1 lakh crore for power transmission projects in current financial year. The decision of government is to bring private sector investment in the industry. Government is  focused on providing 24x7 power for all in next five years. 

As the Greek Crises Prolongs the Asian market Stocks Fell

Monday, 29 June 2015, the whole Asian market skid as investors hurried to exit riskier assets in line with global selloff because of the fear of Greece which could default on a debt repayment and smash out of the euro-zone.

Markets Flattish, Nifty Holds 8300 Mark

Since the last couple of sessions, the Indian markets have been witnessed selling pressure. In the current scenario the sectorial indices have seen some directionless trades. As a result, the Nifty opened on a flat note at 8333, higher by 13 points. The Sensex was up by 34 points at 27679. Both indices opened higher in the range of 0.13-0.19 per cent.

Intrasoft Technologies Limited buzzing on bourses

ISTL a company with 523.42 crores as market capitalization has delivered 561 percent returns on YTD basis. In one month the returns have been 13.41 percent whereas the Sensex IT has delivered negative 3.42 percent. For a three months period the stock has delivered 56 percent returns and for 1 year period the stock has delivered 672 percent returns. On a 3 year basis the stock has delivered annualized returns of 91.36 percent. Investors are well advised to track developments in this counter. 

Index Trends And Stocks In Action June 30, 2015

The Indian Benchmark indices staged a smart recovery in late afternoon trade, but still ended with heavy losses. Global market saw heavy selling amid mounting concerns over an imminent Greek default after the Greek government approved a referendum to decide on its bailout program.

Market May Remain Volatile On Greece Concern

Asian stocks climbed with U.S. index futures after following the biggest global selloff since 2013, while the euro pared its quarterly advance as investors watch developments in Greece. Since SGX Nifty fell 27 points. Indian markets may remain volatile on Greece concern. The focus Tuesday shifts to whether Greece will default on a USD 1.7 billion payment due to the International Monetary Fund.

L&T group wins orders worth Rs 10102 crore in May and June 2015

On Monday, 29th June 2015 L&T announced BSE that, the Construction arm of L&T has won orders worth Rs 2035 crores across various business segments in June 2015.

Sensex, Nifty Falls, Auto Dives

The Indian markets witnessed a sharp fall in today’s morning session. The most impacted sectors were the stocks of Banking, Auto and Healthcare, as they witnessed basket selling and crashed by more than 1% each. However, indices struggled to trim their loss after mid-session. The Sensex ended the day at 27645 down by 166 points. The Nifty ended the day at 8318 lower by 62 points. Both the indices closed lower by .75 percent each.

Tech Mahindra Has Given Signals For Lower Earnings In Q1FY16

Today, Tech Mahindra announced in its business update, that the company in Q1FY16 has some headwinds and tailwinds which could see a risk of marginal decline in both revenue and EBITDA margin on a sequential basis.

DSIJ Breakfast News

Start your day with DSIJ Breakfast Roundup, wind up with DSIJ Market Roundup. Register now to get the day’s market outlook, global cues, economic trends, top corporate news delivered straight to your inbox.

mail to

Start your day with DSIJ Breakfast Roundup, wind up with DSIJ Market Roundup. Register now to get the day’s market outlook, global cues, economic trends, top corporate news delivered straight to your inbox.

mail to  *


(* No Research/Stock Queries)
Name :
Email ID :
Cell Number :
Message :